Background
==========

In late April 2003, Taiwan was stroked by an epidemic of severe acute respiratory syndrome (SARS). A general SARS panic spread over the country when the Taipei Municipal Hoping hospital announced its shutdown as a preventive measure following heavy hospital infection. Further closedown of medical services, including emergency services, appeared sporadically in other hospitals and clinics all over the country. This caused great anxiety among all health care workers. On May 4, 2003, a suspected SARS patient with respiratory failure was brought to the Emergency Service of the Mackay Memorial Hospital in Taipei. The patient was admitted into SARS wards and died 24 hours later. However, during this short period the patient most likely infected 4 health care workers and 5 individuals who were either patients or visiting family members of other patients present at the same time. The hospital set up emergency procedures, and most manpower was put into caring of SARS patients. Taiwan hospitals were facing an unpredictable and invisible enemy for the first time in recent 50 years. The human leukocyte antigen (HLA) system is widely used as a strategy in the search for the etiology of infectious diseases and autoimmune disorders. In this study we investigated the HLA-class I and II system for evidence of disease association. It was hoped that the discovery of disease susceptibility or a disease protection phenotype in the Taiwan population would help into setting up a preventive screening program for health care workers at risk.

Methods
=======

Patients
--------

In the course of March 19 to May 22, 2003, 93 cases of suspected SARS were reported by Mackay Memorial Hospital in Taipei City and its branch in Tan Sui County of Taipei to the Center for Disease Control in Taiwan. Up until early June, among 680 probable SARS cases reported in Taiwan, 71 (10.4%) cases were admitted to our hospital. Between May 5 and 26, 2003, 63 EDTA blood samples from fever patients with respiratory illness were collected in our hospitals. Two earlier specimens from the National Taiwan University Hospital (Taipei) were added to this study. Of the 65 (63+2) cases, 37 cases (table [1](#T1){ref-type="table"}) were diagnosed as probable SARS cases according to updated WHO case definition for SARS (revised May 1, 2003) \[[@B1]\]. Three families were included (cases 31 and 32; cases 33 and 34; and cases 35, 36 and 37). Only the first infected patient in each family (cases 31, 33, 35) was retained for the analysis giving a final count of 33 probable SARS patients. Nine unrelated individuals (cases 7, 13, 18, 19, 21, 22, 26, 27, and 31) were infected from the same source (unfortunately this \"super-spreader\" probable SARS patient died 24 hours after admission in hospital and was not studied). Twenty eight cases of the 65 cases were not positive for SARS, and were referred as \"Excluded fever patients\" in tables [2](#T2){ref-type="table"} and [4](#T4){ref-type="table"}. Among the \"Excluded fever patients\" group, two patients showed positive serological tests for *M. pneumonias*, one had tuberculosis, one patient presented lung edema, and the rest had no lung lesions.

###### 

HLA-A, B, DRB1 allele typing of 37 probable SARS patients

  Case no   HLA-A     HLA-B     HLA-DRB1                          
  --------- --------- --------- ---------- ------------ --------- ---------
  1\*       2402      3303      4601       5801         0301      0901
  2\*       0201/07   2402      1525       4601         0901      1202
  3\*       0201/07   2402      1513       4601         0403/06   1202
  4\*       1101/02   1101/02   4001       4601         0901      1401/07
  5         1101/02   3303      4601       5801         0403/06   0901
  6         0201/07   1101/02   4601       5502         0901      0901
  7†        1101/02   1101/02   4601       5401         1101/04   1501/02
  8         0201/07   2402      4601       1501/12/19   0901      1501/02
  9         0201/07   3303      4601       5801         0803      1301/02
  10        0203      2402      4601       5201         1001      1602
  11        0201/07   3303      4601       4601         0901      1101/04
  12        0201/07   1101/02   5201       5401         0405/10   1001
  13†       0201/07   2402      5401       5801         0301      0405/10
  14        1101/02   2402      1502       5401         0405/10   1401/07
  15        0201/07   1101/02   4001       1502         1202      1501/02
  16        1101/02   2402      5502       4001         0405/10   0901
  17        0203      2402      2704       4001         0403/06   1602
  18†       3303      3303      4001       5801         0301      0901
  19†       0201/07   1101/02   1511       4001         0901      1602
  20        2402      2402      4001       5801         0301      1201
  21†       1101/02   1101/02   3901       4001         0403/06   1401/07
  22\* †    1101/02   2402      4001       8101         0901      1312
  23        1101/02   3303      4001       4001         0803      0901
  24        2402      3303      3901       5801         0901      1501/02
  25        1101/02   1101/02   3901       4803         0803      1405
  26†       2402      3303      3901       5801         0301      0901
  27†       0203      1101/02   3802       3901         1101/04   1602
  28        1101/02   3303      5102       5801         0301      1202
  29        1101/02   2402      1502       1502         1202      1202
  30        0201/07   1101/02   1301       4001         1401/07   1501/02
  31†       0201/07   0301      0702       4601         1101/04   1501/02
  32        0301      2402      0702       5502         1401/07   1501/02
  33\*      0201/07   0201/07   4601       4601         0901      1405
  34        0201/07   1101/02   4601       4001         0901      1501/02
  35        0201/07   1101/02   5401       1502         0405/10   1401/07
  36        0201/07   1101/02   5401       4001         0405/10   1401/07
  37        1101/02   1101/02   4001       1502         1401/07   1405

Cases 31 and 32; cases 33 and 34 are mother- daughter pairs. Case 35 is the father of cases 36 and 37 \* Fatal cases and one severe respiratory failure patient who survived after intubation (case 33). † Individuals most likely infected by the same probable SARS patient who died 24 hrs after admission.

###### 

Allele odds ratios analysis between probable SARS patients and other groups

  ---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
                     **33 Cases**\   **28 fever**\   **Control A**\                    **Control B^†^**\                                                                           
                     **Probable**\   **patients**    **101 high risk non-infected**\   **190 healthy unrelated Taiwanese**                                                         
                     **SARS**\                       **health care workers**                                                                                                       
                     **patients**                                                                                                                                                  
  ------------------ --------------- --------------- --------------------------------- ------------------------------------- ------ ------------- ------ ---- ------ ------------- ------
  **B\* 4601/B46**   15              9               n.s.                              25                                    2.08   1.04--4.24    0.04   52   1.86   1.02--3.54    0.06

  **B\* 1301/B13**   1               3               n.s.                              18                                    0.16   0.02--1.00    0.03   34   0.16   0.02--0.97    0.02

  **B\* 5401/B54**   5               3               n.s.                              3                                     5.44   1.26--23.41   0.02   15   1.99   1.01--5.69    n.s.

  **B\* 3901/B39**   5               2               n.s.                              6                                     2.68   0.78--9.08    n.s.   8    3.81   1.21--12.03   0.03
  ---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

*P*= *P-value*n.s. = not significant. ^†^In control B, HLA-A and B were defined by serological methods. Consequently data were re-analyzed after converting allotypes of probable SARS patients to their serological equivalents \[[@B8]\]. ^‡^Odds ratio (OR) refers to Woolf-Haldane odds ratios, with 95% Woolf approximation confidence intervals (CI) and corresponding two tails Fisher *P-values*. Note: No corrected *P-values*(*Pc-values*) were significant; consequently *Pc-values*were not indicated.

###### 

HLA-B\* 4601 allele and 6 deceased or intubated probable SARS patients

  Case no   Gender   Age   HLA-B allele         Associated clinical conditions                                      Outcome
  --------- -------- ----- -------------------- ------------------------------------------------------------------- ---------------------
  1         F        47    B\* 4601, B\* 5801   None                                                                Intubated, died
  2         F        26    B\* 1525, B\* 4601   Pregnancy (3rd trimester)                                           Intubated, died
  3         M        53    B\* 1513, B\* 4601   None                                                                Died
  4         F        43    B\* 4001, B\* 4601   None                                                                Died
  22        M        91    B\* 4001, B\* 8101   Chronic renal insufficiency, peptic ulcer, coronary heart disease   Died
  33        F        50    B\* 4601, B\* 4601   None                                                                Intubated, survived

###### 

Effect of HLA-B\* 4601 allele on severity of SARS patients

  -------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
               5 deceased or intubated probable SARS patients (Severe cases)   28 Excluded fever patients         Control A\                                                                                                                                                    
                                                                                                                  101 high risk non-infected health care workers                                                                                                                
  ------------ --------------------------------------------------------------- ---------------------------------- ------------------------------------------------ ------------- ------- ------------------- ----------------------------------- ------- ------------- -------- -------------------
  HLA allele   Total number of alleles (n = 10)                                Total number of alleles (n = 56)   OR                                               CI            *P*     *Pc-value*(20)^†^   Total number of alleles (n = 202)   OR      CI            *P*      *Pc-value*(33)^†^

  B\* 4601     6                                                               9                                  7.83                                             1.83--33.47   0.007   n.s.                25                                  10.62   2.80--40.26   0.0008   0.0279
  -------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

n= count of alleles; *P*= *P-value*; n.s. = not significant. ^†^The correction factor (number of different alleles or number of comparisons) is shown within parenthesis; *Pc-value*= *P*× Correction factor (Edward, 1974).

Clinical symptoms, of the 37 patients diagnosed as probable SARS cases, were as follows: 92% (34 cases) showed diffuse infiltration of both lungs and 8% (3 cases) showed only solitary lung lesion; 65% (24 cases) showed at least one positive test result for SARS-CoV RNA by RT-PCR \[[@B2]\] or by real time PCR (Artus, Germany). In addition, the following laboratory data was obtained from the 35 probable SARS patients managed in our hospital: 27% (10 cases) with reduced platelet count (\<150×10^-9^/liter), 59% (22 cases) with lymphocytopenia (\<1×10^-9^/liter), 70% (26 cases) with elevated LDH, 5% (2 cases) with elevated creatine kinase, 54% (20 cases) with elevated AST and /or ALT and 68% (25 cases) with elevated C-reactive protein. Fourteen cases were also tested for HBsAg, all showed negative results.

Serum samples from 27 probable SARS cases were tested for *Chlamydia pneumoniae*, *C. psittaci*and *C. trachomatis*(Chlamydia IgM kit, Savyon Diagnostic, Israel), and 11 were further tested for IgG and IgA antibodies. All showed negative results. Among 24 probable SARS cases who had been tested for *M. pneumoniae*(IgM, Savyon Diagnostic, Israel), only two cases tested positive. These two cases also had diffuse bilateral lung lesions and positive SARS-CoV RNA test. It is possible that 8% of probable SARS cases were co-infected with *M. pneumoniae*. Finally, 15 cases were also tested for *Legionella pneumophilia*serogroup 1 antigen (Binax, US), and showed negative results.

All 37 probable cases revealed history of close or indirect contact with another suspected probable case of SARS. Three patients with severe respiratory failure airways had been intubated and mechanical ventilation was applied during hospitalization. Later, two patients died and one survived. Finally, among the 35 probable SARS cases of our hospital four patients died during hospitalization, giving an 11% mortality rate. Except for two rapid severe/fatal cases most probable SARS patients were admitted to the SARS wards for periods longer than two weeks. A final diagnosis of \"probable SARS\" was declared upon exclusion of all other possible causes.

In brief, 33 cases of \"probable SARS patients\" and 28 \"Excluded fever patients\" were retained for the analysis. This study was performed with approval of the ethics committee of the Mackay Memorial Hospital in Taipei.

Controls
--------

### Control A

Blood samples were obtained at the end of May 2003 from 62 health care workers who had possibly been exposed to coronavirus and were not infected. These 62 health care workers were either working at emergency services, SARS wards (doctors and nurses) or at the out patient clinic (phlebotomists) of our hospital in May 2003. These 62 health care workers were included in control A (table [2](#T2){ref-type="table"}) and had followed World Health Organization (WHO) vigorous measures against infection. Another 39 blood samples from non-infected health care workers from the Taipei Municipal Hoping Hospital were added to control A. These 39 controls had been treating SARS patients in April 2003 without adequate protection from infection, and about 10% of health care workers from the same wards developed probable SARS. In brief, 101 high risk non-infected health care workers were retained as control A for the analysis. Informed consent was obtained from all subjects.

### Control B

HLA-A, B and DRB1 typing of 190 normal healthy, unrelated Taiwanese was obtained from data collected in our laboratory and used as control B. For control B, HLA-A, B class I typing was performed by serological methods only \[[@B3]\]. HLA-DRB1 typing was performed by allele typing as described below for the other groups.

HLA allele typing
-----------------

Blood samples were collected in EDTA vacutainers. Buffy coat were lysed and genomic DNA was isolated by using proteinase K treatment and Q1Aamp blood kit (Q1Agen, Hilden, Germany) according to the manufacturer\'s instructions. Suspected SARS samples were processed in a bio-safety level-3 environment. Medium resolution allele typing for HLA-A, B and DRB1 loci was performed using PCR amplification followed by sequence-specific oligonucleotide probing (PCR-SSOP), (Dynal Biotech Ltd; Wirral, U.K.). Amplified sequences were hybridized to arrays of immobilized probes (35 probes for HLA-A, 56 for HLA-B, and 38 for HLA-DRB1).

Statistical analysis
--------------------

HLA class I and class II allele frequencies were estimated by direct counting assuming that there was no blanks. Odds ratios (OR) were obtained from standard contingency table analysis using Haldane\'s modification of Woolf\'s method \[[@B4],[@B5]\]. Statistical significance was performed by a two tails Fisher\'s exact test \[[@B6]\]. Since small size samples were used in the analysis, the risk of introducing a bias in estimating the probability (*P-value*) and wrongly accepting association (type I error) was corrected using the method of Edwards (7). In this method the P-value is multiplied by the number of independent comparisons at every locus, thereby giving a more powerful corrected *P-value*(*Pc-value*) that may be interpreted with confidence. Lastly, when analyzing serological data, data in the patient group were converted to serology typing using the World Health Organization nomenclature (WHO) table of correspondence \[[@B8]\].

Results
=======

In this study we performed allele typing on 37 probable SARS cases, 28 fever patients of suspected SARS (these 28 patients were later excluded for being non SARS patients), and 101 health care workers (control A) exposed or possibly exposed to SARS coronavirus but non-infected health care workers from Mackay Memorial Hospital and Taipei Municipal Hoping Hospital in Taiwan. HLA-A, B and DRB1 allele typing using PCR-SSOP method was performed on these cases. The HLA data of 190 healthy unrelated Taiwanese in our data bank was also used in this study as control B. HLA alleles typing of 37 probable SARS cases are shown in table [1](#T1){ref-type="table"}.

Analysis between 33 retained unrelated probable SARS cases, 28 excluded fever patients, and two control groups (table [2](#T2){ref-type="table"}) showed weak association to infection of HLA class I alleles (B\* 4601, OR = 2.08, *P*= 0.04, *Pc*= *n.s.*and B\* 5401, OR = 5.44, *P*= 0.02, *Pc*= *n.s.*with control A; and B\* 3901/B39, OR = 3.81, *P*= 0.03, *Pc*= *n.s.*with control B). HLA-B\* 4601 was not significant (*n.s*.) when testing analogous serotypes of the 33 probable SARS patients against the 190 healthy unrelated Taiwanese of control B (OR = 1.86, *P*= 0.06, *Pc*= *n.s.*) (table [2](#T2){ref-type="table"}). HLA-B\* 1301 is a common HLA allele in Taiwan, the number of HLA-B\* 1301 alleles seen in control A and control B were 18 (8.9%) and 34 (8.9%), respectively (table [2](#T2){ref-type="table"}). Unexpectedly, only one HLA-B\* 1301 allele was found among the 33 probable SARS cases (case 30, table [1](#T1){ref-type="table"}, [2](#T2){ref-type="table"}). When testing HLA-B\* 1301 with the 33 probable SARS cases, both control A and control B showed elevated odds ratios (OR = 0.16, *P*= 0.03, *Pc*= *n.s.*and OR = 0.16, *P*= 0.02, *Pc*= *n.s*., respectively).

The 33 probable SARS patients also included 6 severe cases among whom three were patients who had been intubated for mechanical ventilation and five were deceased (table [1](#T1){ref-type="table"}). Except for case 22 (table [1](#T1){ref-type="table"} and [3](#T3){ref-type="table"}), the remaining five cases carried HLA-B\* 4601. Case 22, however was a 91 years old man suffering from chronic renal failure, peptic ulcer and coronary heart disease. The cause of death of this patient was unlikely due to SARS alone and the case was removed from this group. The remaining 5 cases, labeled \"Deceased or intubated probable SARS patients\" in table [4](#T4){ref-type="table"}, were retained for the analysis on the severity of SARS. The association of HLA class I and the severity of SARS was evidenced by an important increase of the odds ratio of HLA-B\* 4601 in the deceased or intubated probable SARS patient group against all other groups, notably with the 28 excluded fever patients (OR = 7.83, *P*= 0.007, *Pc*= *n.s.*) and with control A (OR = 10.62, *P*= 0.0008, *Pc*= 0.0279) (table [4](#T4){ref-type="table"}). HLA-B\* 5401 and HLA-B\* 3901/B39 did not show association with the severity of SARS infection (data not shown).

Discussion
==========

HLA-B gene was found to be associated with susceptibility or protection from infection when analyzing descendants of Dutch colonists\' survivors of 19^th^Century yellow fever and typhoid epidemics \[[@B10]\]. Other studies also indicated that HLA variations were associated with susceptibility or resistance to malaria, tuberculosis, leprosy, HIV and hepatitis virus persistence \[[@B11],[@B12]\]. In ethnic Thai, HLA-A and B alleles were confirmed to be associated with disease severity and clinical outcome of exposure to dengue virus in previously exposed immunologically primed individuals \[[@B13]\]. Moreover, direct evidence of human coronavirus OC43 interaction with HLA class I molecules at the cell surface to establish infection was also described \[[@B14]\]. Consequently we carried out a study to analyze the relation between HLA class I and class II alleles, in SARS coronavirus infection, and/or the severity of the disease. In this study, no association between HLA class II allele and SARS coronavirus infection was seen. Although HLA-B\* 4601 frequency in the 33 probable SARS patients (table [2](#T2){ref-type="table"}) was only slightly higher than the frequencies seen in control A or control B (*P*= 0.04, *Pc*= n.s. and *P*= 0.06, *Pc*= n.s., respectively). On the contrary, the frequency of HLA-B\* 4601 in the five severe cases (table [4](#T4){ref-type="table"}) was slightly increased when compared to the 28 excluded fever patients (*P*= 0.007, *Pc*= ns), but the difference was clearly significant when compared to control A (*P*= 0.0008, *Pc*= 0.03). This increased HLA-B\* 4601 difference was unique to the five severe cases patients and may indicate association with the severity of SARS. A susceptibly of HLA-B\* 5401/B54 or B\* 3901/B39 to infection rather than to the severity of the disease (table [2](#T2){ref-type="table"}) could not be concluded upon (*Pc*= n.s.) and requires further studies. HLA-B13 is widely distributed throughout Asia \[[@B18]\] where it is mostly represented by HLA-B\* 1301 (4--30%) and rarely by B\* 1302 (0--2%) \[Unpublished data\]. Furthermore, HLA-B13 is seen with frequencies greater than 16% among most indigenous tribes of the central mountain area in Taiwan \[[@B9]\] and in the Taiwanese (9.1%). In this study, we found that presence of HLA-B\* 1301/B13 was decreased in the 33 probable SARS patients when compared with the two control groups A (OR = 0.16, *P*= 0.03, *Pc*= n.s.) or B (OR = 0.16, *P*= 0.02, *Pc*= n.s.). However, only the analysis of a larger case-control data set would confirm or refute association of HLA-B\* 1301 with resistance to coronavirus infection.

Taiwan population is heterogeneous and comprises 91% Taiwanese, 7.5% Chinese who arrived from many different provinces of China after World War II, and 1.5% of indigenous peoples established there since several millenniums. The Taiwanese comprised the Minnan and Hakka people groups, and are the descendants of early settlers from the southeast coast of China (Fujian and Guangdong Provinces) during the last few centuries. The genetic profile of the Taiwanese shows many affinities to southern Asian populations \[[@B3]\] and share the same origin with Singapore Chinese and Thai Chinese who also originated from the southeast coast of China. According to archeological evidences \[[@B15]\], the populations in the delta of the Hong River in northern Vietnam are also likely related to these populations. After the outbreak of SARS coronavirus infection in the Guangdong Province of China, it was surprising to observe that the spreading of the disease was mostly confined among southern Asian populations (Hong-Kong peoples, Vietnamese, Singaporeans and Taiwanese). Density of populations possibly favored the growth of the epidemic. The question aroused as to whether affected southern Asian populations were more susceptible to SARS infection than peoples of northern China (Beijing), Japan, or Korea. Many peoples in Beijing generally considered as northern Chinese \[[@B16]\], were also infected, however, infection in Beijing could be attributed to heterogeneity of populations following important recent migration of southern Chinese and population resettlement during the Cultural Revolution.

The probable SARS cases in this report consist mainly of southern Chinese origin Taiwanese (non indigenous peoples). Contraction of SARS by Taiwan indigenous individuals from any of the nine tribes of Taiwan has not yet been reported to this day. It is possible that the HLA make up of the Taiwan indigenous peoples has little in common to the Taiwanese \[[@B9]\] and may not contain any element favoring SARS infection. Also, HLA-B\* 4601/B46 displays higher frequencies in Southern Han (15.4%), in Singaporean (15.1%) and in Vietnamese (13.2%) than in Northern Han (2.8%)\[[@B18]\], but the allele has rarely been seen among indigenous peoples \[[@B9]\] except in children of intermarriage between Taiwanese and indigenous peoples \[[@B9]\]. Interestingly, HLA-B\* 4601/B46 is also seldom seen in Europeans populations where very few cases of SARS infection of individuals of European origin were reported \[[@B17]\].

The presence or absence of HLA-B\* 4601 in a population appeared to be an important element that acted during the outbreak of the SARS epidemic. Certainly, further independent studies are still needed to confirm this hypothesis. However, Taiwan indigenous peoples have no HLA-B\* 4601 and have very low population density. This does not exclude that they may have avoided infection only by chance, even though many indigenous peoples are now urbanized and would have run the same risk as Taiwanese. Southern Asian peoples, not only live in highly densely populated regions, but also have less variation in their HLA related immune repertoires than European or African populations \[Variation was inferred here from the heterozygosity (*h*= 1 - sum of squares of allele frequencies) seen in these populations, and *h*was obtained and calculated (data not shown) from published data \[18\]\], which as a whole creates a favorable factor for rapid settling of any epidemic. It becomes evident that authorities must keep a state of disease awareness at all times. Little is known on the routes of infection of SARS coronavirus \[[@B19]\]. In this study, the effect of HLA alleles on the resistance or susceptibility to SARS coronavirus infection was shown to be associated to class I alleles. No association with class II alleles was seen. Quickly establishing a procedure of mass screening for health care workers at risk of exposure to SARS coronavirus by detecting HLA-B\* 4601 and possibly HLA-B\* 1301 alleles appears justified. The results of such screening would help hospitals to better guard their personals against infection, make the workplace safer, and help to ease the tension and anxiety seen in the hospital environment.
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